Basit öğe kaydını göster

dc.contributor.authorŞahan C.
dc.contributor.authorÖztürk M.
dc.date.accessioned2020-06-21T09:14:51Z
dc.date.available2020-06-21T09:14:51Z
dc.date.issued2002
dc.identifier.issn1300-2996
dc.identifier.urihttps://hdl.handle.net/20.500.12712/2547
dc.description.abstractInflammatory bowel disease (IDB) is systemic disorder. An increased risk of arterial and venous thrombosis was originally reported by Borgen and Barker in 1936. Clinically, it is seen only 1-3% of patients admitted to the hospital for IBD. Ulcerative colitis may be complicated by macrovascular thrombosis. The most common manifestations are deep vein thrombosis of the leg and pulmonary emboli. Several mechanisms have been described which might explain an increased tendency for thromboembolic events in patients with IBD. Genetic risk factors for venous thrombosis are classified as deficiencies of protein C, protein S, antitrombin III, factor V leiden and protrombin 20210, hyperhomocysteinemia.en_US
dc.language.isoturen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHyperhomocysteinemiaen_US
dc.subjectThrombosisen_US
dc.subjectUlcerative colitisen_US
dc.titleUlcerative colitis and thrombosisen_US
dc.title.alternativeÜlseratif kolit ve trombozen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume19en_US
dc.identifier.issue4en_US
dc.identifier.startpage287en_US
dc.identifier.endpage290en_US
dc.relation.journalOndokuz Mayis Universitesi Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster